Gastric Glitch: A New Functional Disease Treated with Buspirone and Prucalopride in an N-of-1 Double-Blind Clinical Trial

Clin Drug Investig. 2023 Jan;43(1):75-78. doi: 10.1007/s40261-022-01221-y. Epub 2022 Nov 12.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Letter

MeSH terms

  • Benzofurans* / therapeutic use
  • Buspirone* / therapeutic use
  • Double-Blind Method
  • Humans
  • Serotonin 5-HT4 Receptor Agonists

Substances

  • Buspirone
  • prucalopride
  • Benzofurans
  • Serotonin 5-HT4 Receptor Agonists